Accuitis Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

Accuitis General Information

Description

Operator of a clinical-stage pharmaceutical company focused on the development of new drugs to address under-served disease states. The company specializes in developing and marketing drug therapies for the treatment of rosacea and other topical skin and eye diseases, providing patients with drugs for the treatment of rosacea.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1005 Alderman Drive
  • Suite 104
  • Alpharetta, GA 30024
  • United States
+1 (678) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuitis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Accuitis‘s full profile, request access.

Request a free trial

Accuitis Executive Team (5)

Name Title Board Seat Contact Info
Richard Coulon Co-Founder, President Chief Executive Officer & Board Member
Michael Shippel Co-Founder, Chief Financial Officer & Board Member
Mark Jackson MD Medical Consultant
Jack Arbiser Ph.D Co-Founder & Chief Innovation Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Accuitis Board Members (5)

Name Representing Role Since
00000000 0000000 0 Bio/Med Investor Network Board Member 000 0000
0000000 0000000 Accuitis Co-Founder, Chief Financial Officer & Board Member 000 0000
0000000 000000 Accuitis Co-Founder, President Chief Executive Officer & Board Member 000 0000
000000 000000 00.0 Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Accuitis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accuitis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Accuitis‘s full profile, request access.

Request a free trial